Showing 51 - 60 of 33,997
This article offers a proposal for the regulation of stem cell products by the Food and Drug Administration (“FDA”) that corresponds to a specialized product liability scheme. It shows how product liability and administrative law can be successfully integrated to create a comprehensive legal...
Persistent link: https://www.econbiz.de/10014162099
This chapter describes the market for pharmaceuticals, which exceeded $500 million in sales in 2010. The industry is also characterized by extensive regulation of almost every activity, from product development through manufacturing and marketing, which we summarize. We next describe the...
Persistent link: https://www.econbiz.de/10014025576
Between 1997 and 2000 the Australian government introduced three policy reforms that aimed to increase private health insurance coverage and reduce public hospital demand. The first provided income-based tax incentives; the second gave an across-the-board 30% premium subsidy; and the third...
Persistent link: https://www.econbiz.de/10004991588
Regulation of prescription and dispensing of antibiotics has a twin purpose: to enhance access to antibiotic treatment and to reduce inappropriate use of drugs. Nevertheless, incentives on antibiotics to dispensing physicians may lead to inefficiencies. We model the interaction between competing...
Persistent link: https://www.econbiz.de/10010635279
The regulation on prescribing and dispensing of antibiotics has a double purpose: to enhance access to antibiotic treatment and to reduce the inappropriate use of drugs. Nevertheless, incentives to dispensing physicians may lead to inefficiencies. We sketch a theoretical model of the market for...
Persistent link: https://www.econbiz.de/10005113160
This CPB Discussion Paper presents new estimates for the price elasticity of the residual demand for health insurance. This elasticity measures the loss in market share of a health insurer as a consequence of a unilateral increase in price, assuming other firms keep their prices constant. The...
Persistent link: https://www.econbiz.de/10005708036
This dissertation consists of empirical essays within the subject of health economics. There are four essays in applied micro-econometrics and, as data in Essays 2 and 4 have a panel format, econometric methods for panel data are applied. Tobit-type models for limited dependent variables are...
Persistent link: https://www.econbiz.de/10008546348
The purpose of this paper is to investigate how the brand name’s market shares in Tunisia are affected by generic competition during the pre-reform period of the Tunisian health insurance system following the methodological approach developed by Aronsson et al. (2001). In this study we use...
Persistent link: https://www.econbiz.de/10008551692
This study exploits a natural experiment in Belgium to estimate the effect of co-payment increases on the demand for physician services. It shows how a differences-in-differences estimator of the price effects can be decomposed into effects induced by the common average proportional price...
Persistent link: https://www.econbiz.de/10004985057
This paper examines the demand for complementary health insurance (CHI) in the non-group market in France and the reasons why the near poor seem price insensitive. First we develop a theoretical model based on a simple tradeoff between two goods: CHI and a composite good reflecting all other...
Persistent link: https://www.econbiz.de/10005074023